Article Details

ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting ...

Retrieved on: 2024-03-07 18:09:00

Tags for this article:

Click the tags to see associated articles and topics

ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting .... View article details on hiswai:

Excerpt

London, UK - ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo